We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Increased Ventricular Arrhythmias and No Improvement in Death Rate for COVID-19 Patients Who Received Hydroxychloroquine

News   May 23, 2020 | Original story by Brigham and Women’s Hospital

 
Increased Ventricular Arrhythmias and No Improvement in Death Rate for COVID-19 Patients Who Received Hydroxychloroquine

Credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Which Drugs Are Being Used To Treat COVID-19?

News

With doctors and researchers around the world searching for effective treatments for COVID-19, many drugs approved to treat other diseases are being used in hopes that they’ll be effective against the virus. Researchers have cataloged every use documented in medical literature so far and found physicians have reported on the use of more than 100 different treatments.

READ MORE

Team Inhibits Molecule in Myeloid Cells To Shrink Tumors

News

Inhibiting a molecule hijacked by tumor cells to suppress the immune system shrank tumors in cell and mouse models.

READ MORE

Early Immunological Studies Show Universally Effective Antibodies Against SARS-CoV-2 in Recovered Humans

News

The first round of results from an immunological study of 149 people who have recovered from COVID-19 show that although the amount of antibodies they generated varies widely, most individuals had generated at least some that were intrinsically capable of neutralizing the SARS-CoV-2 virus.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE